Inhibition by aripiprazole of dopaminergic inputs to striatal neurons from substantia nigra

Psychopharmacology

Volumn 146, Issue 2, 1999, Pages 139-143

  Matsubayashi, Hiroaki ^a   Amano, Taku ^a   Sasa, Masashi ^a  

^a HIROSHIMA UNIV SCHOOL OF MEDICINE   (Japan)

Author keywords

Aripiprazole; Corpus striatum; Dopamine D2 receptor; Extracellular recording in vivo; Iontophoretic application

Indexed keywords

ARIPIPRAZOLE; DOMPERIDONE; DOPAMINE 2 RECEPTOR BLOCKING AGENT; DOPAMINE 2 RECEPTOR STIMULATING AGENT; GLUTAMIC ACID; QUINPIROLE;

ARTICLE; BRAIN ELECTROPHYSIOLOGY; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINERGIC SYSTEM; DOSE RESPONSE; DRUG EFFECT; DRUG MECHANISM; DRUG STRUCTURE; MALE; MICROIONTOPHORESIS; NONHUMAN; PRIORITY JOURNAL; RAT; SUBSTANTIA NIGRA;

ANIMALS; ANTIPSYCHOTIC AGENTS; DOMPERIDONE; DOPAMINE; DOPAMINE ANTAGONISTS; ELECTRIC STIMULATION; ELECTROPHYSIOLOGY; EVOKED POTENTIALS; EXTRACELLULAR SPACE; MALE; MICROELECTRODES; NEOSTRIATUM; NEURONS; PIPERAZINES; QUINOLONES; RATS; RATS, WISTAR; SUBSTANTIA NIGRA;

EID: 0032846559     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002130051099     Document Type: Article

References (22)

1. Akaike A, Ohno Y, Sasa M, Takaori S (1987) Excitatory and inhibitory effects of dopamine on neuronal activity of the caudate nucleus neurons in vitro. Brain Res 418:262-272
2. Amano T, Matsubayashi H, Momiyama T, Ishihara K, Todo N, Sasa M (1995) Antagonizing effects of a novel antipsychotic quinolinone derivative (OPC-14597) on dopaminergic inhibition of neuronal activities in the nucleus accumbens. Prog Neuro-Psychopharmacol Biol Psychiatry 19:105-106
3. Benkert O, Muller-Siecheneder F, Wetzel H (1995) Dopamine agonists in schizophrenia: a review. Eur Neuropsychopharmacol 5:43-53
4. Inoue T, Domae M, Yamada K, Furukawa T (1996) Effects of the novel antipsychotic agent 7-{4-[4-(2,3-dichlorophenyl)-1-piperazinyl]butyloxy} -3,4-dihydro-2(1H)-quinolinone(OPC-14597) on prolactin release from the rat anterior pituitary gland. J Pharmacol Exp Ther 277:137-143
5. 2 receptor, on tyrosine hydroxylation in rat striatal slices. Life Sci 42:343-349
6. 2 receptor antagonistic activity. J Pharmacol Exp Ther 274:329-336
7. Lahti AC, Weiler MA, Corey PK, Lahti RA, Carlsson A, Tamminga CA (1998) Antipsychotic properties of the partial dopamine agonist (-)-3-(3- hydroxyphenyl)-N-n-propylpiperidine(preclamol) in schizophrenia. Biol Psychiatry 43:2-11
8. 3H]hydroxy-N,N-di-n-propyl-2-aminotetralin. Proc Natl Acad Sci USA 89:8155-8156
9. Matsubayashi H, Amano T, Honging Y, Kohno Y, Sasa M (1995) Action of intravenously administered talipexole on the rat striatal neurons receiving excitatory input from nigral dopamine neurons. Psychopharmacology 120:369-375
10. Momiyama T, Sasa M, Takaori S (1990) D-2 receptor-mediated inhibition by a substituted quinolinone derivative, 7-[3-(4-(2,3-dimethylphenyl) piperazinyl)propoxy]-2(1H)-quinolinone (OPC-4392), of dopaminergic neurons in the ventral tegmental area. Life Sci 47:761-769
11. Momiyama T, Amano T, Todo N, Sasa M (1996) Inhibition by a putative antipsychotic quinolinone derivative (OPC-14597) of dopaminergic neurons in the vental tegmental area. Eur J Pharmacol 310:1-8
12. 2 agonist, in the treatment of negative symptoms of chronic schizophrenia. Biol Psychiatry 33:687-693
13. Ohno Y, Sasa M, Takaori S (1985) Dopamine D-2 receptor-mediated excitation of caudate nucleus neurons from the substantia nigra. Life Sci 37:1515-1521
14. Ohno Y, Sasa M, Takaori S (1986) Excitation by dopamine D-2 receptor agonists, bromocriptine and LY171555 in caudate neurons activated by nigral stimulation. Life Sci 38:1867-1873
15. Ohno Y, Sasa M, Takaori S (1987) Coexistence of inhibitory dopamine D-1 and excitatory D-2 receptors on the same caudate nucleus neurons. Life Sci 40:1937-1945
16. Paxinos G, Watson C (1986) The rat brain in stereotaxic coordinates, 2nd edn. Academic Press, Sydney
17. Sasa M, Amano T (1997a) Unique pharmacological profile of a novel antipsychotic drug, aripiprazole (OPC-14597). CNS Drug Rev 3:24-33
18. 3 receptors. Jpn J Psychopharmacol 17:97-100
19. Seeman P, Van Tol HH (1994) Dopamine receptor pharmacology. Trends Pharmacol Sci 15:264-270
20. Semba J, Watanabe A, Kito S, Toru M (1995) Behavioural and neurochemical effects of OPC-14597, a novel antipsychotic drug, on dopaminergic mechanisms in rat brain. Neuropharmacology 37:785-791
21. 2 agonist, of caudate nucleus neurons activated by nigral stimulation. Life Sci 54:957-966
22. Toru M, Miura S, Kudo Y (1994) Clinical experiences of OPC-14597, a dopamine autoreceptor agonist, in schizophrenic patients. Neuropsychopharmacology 10:122S